BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2026 3:52:16 AM | Browse: 77 | Download: 323
Publication Name World Journal of Clinical Cases
Manuscript ID 119413
Country Italy
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Minireviews
Article Title Gene therapy for diabetic retinopathy
Manuscript Source Invited Manuscript
All Author List Matteo Capobianco, Simonetta Gaia Nicolosi, Francesco Cappellani, Marieme Khouyyi, Fabiana D’Esposito, Caterina Gagliano and Marco Zeppieri
ORCID
Author(s) ORCID Number
Fabiana D’Esposito http://orcid.org/0000-0002-7938-876X
Caterina Gagliano http://orcid.org/0000-0001-8424-0068
Marco Zeppieri http://orcid.org/0000-0003-0999-5545
Funding Agency and Grant Number
Corresponding Author Marco Zeppieri, Consultant, MD, PhD, Postdoc, Department of Ophthalmology, University Hospital of Udine, p. le S. Maria della Misericordia 15, Udine 33100, Italy. mark.zeppieri@asufc.sanita.fvg.it
Key Words Diabetic retinopathy; Diabetic macular edema; Gene therapy; Retinal biofactory; Adeno-associated virus; Suprachoroidal delivery; Inflammation; Neurovascular unit; Genome editing
Core Tip Gene therapy for diabetic retinopathy is developing as a method to diminish the want for regular intravitreal injections by offering prolonged intraocular modulation of disease pathways. Extensive experience with age-related macular degeneration provides compelling clinical evidence that sustained suppression of pathological vascular signaling is feasible, while preliminary studies on diabetic retinopathy are evaluating the potential for similar durability within the inflammatory diabetic retinal milieu. Significant obstacles to translation encompass delivery- and dose-associated intraocular inflammation, ambiguity concerning long-term efficacy and the practicality of repeated dosage, as well as the necessity for stringent patient selection and monitoring.
Publish Date 2026-04-09 03:52
Citation

Capobianco M, Nicolosi SG, Cappellani F, Khouyyi M, D’Esposito F, Gagliano C, Zeppieri M. Gene therapy for diabetic retinopathy. World J Clin Cases 2026; 14(11): 119413

URL https://www.wjgnet.com/2307-8960/full/v14/i11/119413.htm
DOI https://dx.doi.org/10.12998/wjcc.v14.i11.119413
Full Article (PDF) WJCC-14-119413-with-cover.pdf